**Case description:** Gout is the most common form of inflammatory arthropathy with prevalence around 2.5% in UK. Deposition of monosodium urate crystals in the synovium is the primary pathology manifesting as arthritis. A 42 year old gentleman who was known to have tophaceous gout since the age of 17 & strong family history of gout, developed recurrent severe gouty attacks. He was taking allopurinol 300mg and indomethacin regularly. Patient was a keen body builder and was taking regular protein supplement. His bloods revealed progressive rise in creatinine and uric acid levels. Patient was evaluated by renal team who did renal biopsy and diagnosis of IgA nephropathy was made. Patient went on to develop end stage renal failure and eventually had a renal transplant. Patient's gout got worse with the onset of renal dysfunction. Patient's uric acid levels continued to rise. Despite increasing the dose of allopurinol and regular colchicine patient continued to have very high uric acid levels and intermittent attacks of gout. Due to rising creatinine allopurinol was switched with febuxostat. Febuxostat dose was increased to 120mg due to high urate levels whilst on 80mg. His urate levels went up whilst on febuxostat 120mg. His kidney function declined further and febuxostat dose was reduced to 80mg. Patient became dialysis dependant whilst awaiting renal transplant. His uric acid levels came down from 766 to 433 umols/L.

**Discussion:** Patient underwent renal transplant. Post renal transplant patient continued to have severe gout flares although his uric acid levels reached 295umols/L. Patient was taking colchicine, prednisolone & febuxostat 120mg at that time. His febuxostat was reduced to 80mg and eventually weaned off due to persistent gouty attacks. Patient's urate levels rose to 635umols/L after cessation of febuxostat and henceforth febuxostat was reintroduced. Urate levels came down to 416umols/L but patient's gout got much worse. Sulfinpyrazone was added to the prescription. His urate levels came down to 377umols/L. Patient developed abnormal liver functions with elevated alanine transaminase. Sulfinpyrazone was stopped and feboxostat dose was reduced to 80mg. Patient continued with muscle building & protein supplements despite medical advice. His uric acid levels started to rise again along with gout flares. Patient came off his febuxostat and currently on colchicine 500mcg BD, prednisolone 5mg.

**Key learning points:** Is there a role for combination therapy?
